These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 15581096)
1. [Endocannabinoids receptor blocker lets tumble not only money. A drug against metabolic syndrome?]. Aumiller J MMW Fortschr Med; 2004 Nov; 146(45):12. PubMed ID: 15581096 [No Abstract] [Full Text] [Related]
2. [In diabetes cannabinoid antagonist kills two birds with one stone]. MMW Fortschr Med; 2005 Sep; 147(35-36):10. PubMed ID: 16180564 [No Abstract] [Full Text] [Related]
3. [A new pill for metabolic syndrome. Successful control of lipids, kilos and cigarettes]. Einecke D MMW Fortschr Med; 2004 Mar; 146(13):10-1. PubMed ID: 15219119 [No Abstract] [Full Text] [Related]
5. [Pharmacology of cannabinoid receptors]. Le Fur G; Rinaldi-Carmona M; Barth F; Alexander J Bull Acad Natl Med; 2007; 191(4-5):933-8; discussion 938-40. PubMed ID: 18225447 [TBL] [Abstract][Full Text] [Related]
6. [Rimonabant--a panacea for patients with metabolic syndrome?]. Broncel M; Koziróg M Pol Arch Med Wewn; 2006 Aug; 116(2):787-93. PubMed ID: 17424926 [No Abstract] [Full Text] [Related]
7. [Positive influence on cardiovascular risk factor by blocking the endocannabinoid system]. Chatterjee T; Ritz A; Ince H; Nienaber ChA; Rehders TC Praxis (Bern 1994); 2008 May; 97(11):613-21. PubMed ID: 18592956 [TBL] [Abstract][Full Text] [Related]
8. Rimonabant as potential treatment for the neglected epidemic of diabetes in the Middle East and Arabian Peninsula. Implication for prevention. Ahmed MH Saudi Med J; 2007 May; 28(5):806-8. PubMed ID: 17457461 [No Abstract] [Full Text] [Related]
9. [Endocannabinoids--the new option in the treatment of metabolic syndrome and in smoking cessation]. Kvasnicka T Cas Lek Cesk; 2005; 144(2):81-4; discussion 85. PubMed ID: 15807291 [TBL] [Abstract][Full Text] [Related]
10. Rimonabant: a cannabinoid receptor blocker for the treatment of metabolic and cardiovascular risk factors. Tonstad S Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):156-62. PubMed ID: 16487916 [TBL] [Abstract][Full Text] [Related]
11. [A drug for therapy of obesity: really only life style? (interview by Dirk Einecke)]. Wirth A MMW Fortschr Med; 2006 Nov; 148(46):17. PubMed ID: 17615781 [No Abstract] [Full Text] [Related]
12. The endocannabinoid system and cardiovascular risk: pathophysiologic role and developing therapeutic interventions. Sander GE; Giles TD Am J Geriatr Cardiol; 2006; 15(4):255-9. PubMed ID: 16849895 [No Abstract] [Full Text] [Related]
13. Does a weight loss medicine make sense for obese type 2 diabetes? New information on endocannabinoid blockers. McCall AL Curr Diab Rep; 2007 Oct; 7(5):329-32. PubMed ID: 18173964 [No Abstract] [Full Text] [Related]
14. [Residual risk in cardiovascular prevention]. Rapezzi C; Volpe M G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):18S-22S. PubMed ID: 18773747 [TBL] [Abstract][Full Text] [Related]
15. Endocannabinoids--the brain's own marijuana--may be linked to the metabolic syndrome. Griffing GT MedGenMed; 2006 Oct; 8(4):7. PubMed ID: 17415289 [No Abstract] [Full Text] [Related]
16. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. Després JP; Golay A; Sjöström L; N Engl J Med; 2005 Nov; 353(20):2121-34. PubMed ID: 16291982 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program. Van Gaal L; Pi-Sunyer X; Després JP; McCarthy C; Scheen A Diabetes Care; 2008 Feb; 31 Suppl 2():S229-40. PubMed ID: 18227491 [TBL] [Abstract][Full Text] [Related]
19. [Endocannabinoid and endocannabinoid receptor antagonists]. Heinzl S Med Monatsschr Pharm; 2005 Feb; 28(2):40-3. PubMed ID: 15727333 [No Abstract] [Full Text] [Related]
20. The endocannabinoid system as a target for the treatment of visceral obesity and metabolic syndrome. Kyrou I; Valsamakis G; Tsigos C Ann N Y Acad Sci; 2006 Nov; 1083():270-305. PubMed ID: 17148745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]